Did you know that your browser is out of date?
For the best experience we recommend upgrading to the latest version of these supported browsers:
I wish to continue viewing on my unsupported browser
For the best experience we recommend upgrading to the latest version of these supported browsers:
I wish to continue viewing on my unsupported browser
Understanding the economics of valuation is essential in all but the simplest of settings. NERA provides valuation expertise in three general contexts: business valuation, tangible asset valuation, and financial asset valuation.
In the context of business and tangible asset valuation, NERA has utilized valuation methodologies which are based on company comparables and earnings multiples, the values of other assets from the same company or portfolio, financial modeling and estimation of the company's future cash flows, and comparisons to valuations of benchmark assets in the public domain.
For financial and quasi-financial assets and derivatives contracts, our valuations techniques leverage generally accepted discounted cash flows and mark-to-market methods, derivatives option models, real options techniques, probability-weighted and dynamic cash flow models, custom simulation models, reference/inference-based comparables approaches, and zero-arbitrage calculation techniques. Our experience in a variety of asset classes allows us to quickly assess market specifics, identify important and potentially unique valuation characteristics of the asset, assess the impact of market economics on market value, and use defendable, industry standard methods to derive a fair valuation. With the ability to combine economics, finance, statistics, and econometrics, NERA’s experts can execute valuation methods that go beyond traditional approaches to valuation, especially in cases where historical data and other valuation benchmarks are either unavailable or considered inadequate.
Name | Title | Location | Phone | |
---|---|---|---|---|
Lucy P. Allen | Managing Director | New York City | +1 212 345 5913 | lucy.allen@nera.com |
Dr. Vinita Juneja |
Managing Director
Chair of NERA's White Collar, Investigations and Enforcement Practice |
New York City
London Toronto |
+1 212 345 3148
+44 20 7659 8618 +1 416 868 7314 |
vinita.juneja@nera.com |
Dr. Denise Neumann Martin | Managing Director | Miami | +1 212 345 5296 | denise.martin@nera.com |
Dr. Faten Sabry |
Managing Director
Chair of NERA's Global Securities and Finance Practice Bankruptcy Practice Chair |
New York City
London |
+1 212 345 3285
+44 20 7659 8618 |
faten.sabry@nera.com |
Dr. David Tabak | Managing Director | New York City | +1 212 345 2176 | david.tabak@nera.com |
Adam Warren | Managing Director | Chicago | +1 (312) 573-2821 | adam.warren@nera.com |
Jorge Baez | Director |
Miami
New York City |
+1 305 341 5060
+1 212 345 5753 |
jorge.baez@nera.com |
Dr. Ling Ling Ang | Associate Director |
New York City
Washington, DC Chicago |
+1 212 345 5409
+1 202 466 9259 +312 573 2827 |
lingling.ang@nera.com |
Dr. Airat Chanyshev | Associate Director | New York City | +1 212 345 7336 | airat.chanyshev@nera.com |
William P. Hrycay | Associate Director | New York City | +1 212 345 1518 | william.hrycay@nera.com |
Erin B. McHugh | Associate Director |
London
New York City |
+44 20 7659 8736
+1 212 345 2990 |
erin.mchugh@nera.com |
Timothy McKenna | Associate Director | New York City | +1 212 345 5503 | timothy.mckenna@nera.com |
Dr. Jordan Milev | Associate Director | New York City | +1 212 345 5516 | jordan.milev@nera.com |
Robert Patton | Associate Director |
Toronto
London New York City |
+1 416 868 7318
+44 20 7659 8620 +1 212 345 3269 |
robert.patton@nera.com |
Dr. Andrew Carron | Affiliated Consultant |
New York City
London |
+1 212 345 5407
+44 20 7659 8500 |
andrew.carron.affiliate@nera.com |
Dr. James Jordan | Affiliated Consultant | Washington, DC | +1 202 466 9263 | james.jordan.affiliate@nera.com |